首頁 › 胰臟癌 › 德克薩斯州 › San Antonio
San Antonio, TX 的 胰臟癌 臨床試驗
31 項針對 胰臟癌 的研究正在 San Antonio（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, San Antonio
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
招募中3 期
- Texas Oncology - San Antonio, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, San Antonio
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US080, San Antonio
- Investigative Site US063, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
招募中1 期
- NEXT, San Antonio
- START - San Antonio, San Antonio
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
招募中觀察性研究
- Children's Hospital of San Antonio, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
招募中2 期
- START- San Antonio, San Antonio
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- START San Antonio, San Antonio
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- University of Texas Health Science Center at San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
招募中1 期
- New Experimental Therapeutics of San Antonio LLC, San Antonio
- START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- NEXT Oncology, San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- START, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Next Oncology, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- NEXT Oncology, San Antonio
A Study of MGC028 in Participants With Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
招募中1/2 期
- NEXT Oncology, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- START San Antonio, San Antonio
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- START San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
招募中1/2 期
- Next Oncology, San Antonio, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
招募中1 期
- Exelixis Clinical Site #3, San Antonio
其他城市的 胰臟癌 試驗
- Houston, TX61 項研究
- New York City, NY60 項研究
- Boston, MA43 項研究
- Nashville, TN39 項研究
- Los Angeles, CA35 項研究
- St. Louis, MO33 項研究
- Arlington, VA33 項研究
- Baltimore, MD31 項研究
- Philadelphia, PA26 項研究
- Tampa, FL26 項研究
- Durham, NC24 項研究
- San Diego, CA24 項研究
San Antonio 的其他研究
- 非小細胞肺癌59 項研究
- 乳癌47 項研究
- 大腸直腸癌46 項研究
- 轉移性癌症44 項研究
- 癌症（所有類型）41 項研究
- 肥胖症40 項研究
- 第二型糖尿病37 項研究
- 過重34 項研究
- 卵巢癌31 項研究
- 前列腺癌28 項研究
- 子宮內膜癌27 項研究
- 肺癌26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。